Randomized Controlled Trial
. 2009 Jul 21;151(2):103-9. doi: 10.7326/0003-4819-151-2-200907210-00007. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics Carol A Burke, H Gilbert Welch, Robert W Haile, Robert S Sandler, E Robert Greenberg, Dennis J Ahnen, Robert S Bresalier, Richard I Rothstein, Bernard Cole, Leila A Mott, John A BaronAffiliations
AffiliationItem in Clipboard
Randomized Controlled Trial
Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristicsDouglas J Robertson et al. Ann Intern Med. 2009.
. 2009 Jul 21;151(2):103-9. doi: 10.7326/0003-4819-151-2-200907210-00007. Authors Douglas J Robertson 1 , Carol A Burke, H Gilbert Welch, Robert W Haile, Robert S Sandler, E Robert Greenberg, Dennis J Ahnen, Robert S Bresalier, Richard I Rothstein, Bernard Cole, Leila A Mott, John A Baron AffiliationItem in Clipboard
AbstractBackground: Suggested intervals for postpolypectomy surveillance colonoscopy are currently based on the adenoma findings from the most recent examination.
Objective: To determine the risk for clinically significant adenoma recurrence on the basis of the results of 2 previous colonoscopies.
Design: Prospective cohort study.
Setting: Academic and private centers in North America.
Patients: Participants in an adenoma chemoprevention trial in which all participants had 1 or more adenoma found on complete colonoscopy at entry. For this analysis, only participants whose qualifying adenoma was their first were included. All participants then underwent second and third study colonoscopies at roughly 3-year intervals.
Measurements: Proportion of patients with high-risk findings at the third study colonoscopy--either at least 1 advanced (> or = 1 cm or advanced histology) adenoma or multiple (> or = 3) adenomas.
Results: Fifty-eight of 564 participants (10.3%) had high-risk findings at the third study examination. If the second examination showed high-risk findings, then results from the first examination added no significant information about the probability of high-risk findings on the third examination (18.2% for high-risk findings on the first examination vs. 20.0% for low-risk findings on the first examination; P = 0.78). If the second examination showed no adenomas, then the results from the first examination added significant information about the probability of high-risk findings on the third examination (12.3% if the first examination had high-risk findings vs. 4.9% if the first examination had low-risk findings; P = 0.015).
Limitation: This observational study cannot specifically examine adenoma recurrence risk at intervals suggested for patients with low-risk adenomas (for example, 5 years vs. 10 years).
Conclusion: Information from 2 previous examinations may help identify low-risk populations that benefit little from intense surveillance. Surveillance guidelines might be tailored in selected patients to use information from 2 previous examinations, not just the most recent one.
Primary funding source: National Institutes of Health.
FiguresFigure 1
Composition of analytic cohort relative…
Figure 1
Composition of analytic cohort relative to those randomized into the parent ASA/Folate trial
Figure 1Composition of analytic cohort relative to those randomized into the parent ASA/Folate trial
Figure 2
Absolute risk of advanced or…
Figure 2
Absolute risk of advanced or multiple adenoma detection on the third colonoscopy stratified…
Figure 2Absolute risk of advanced or multiple adenoma detection on the third colonoscopy stratified on the findings from the first 2 colonoscopies or when only considering the second colonoscopy.
Similar articlesAnderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ. Anderson JC, et al. Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20. Gastroenterology. 2017. PMID: 28219690 Free PMC article. Clinical Trial.
Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z, Cross AJ, Marcus PM, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery ML, Burt R, Iber F, Shike M, Kikendall JW, Lanza E, Schatzkin A. Laiyemo AO, et al. Ann Intern Med. 2008 Mar 18;148(6):419-26. doi: 10.7326/0003-4819-148-6-200803180-00004. Ann Intern Med. 2008. PMID: 18347350 Clinical Trial.
Dong J, Wu M, Miao J, Zhi T, Zhang T, Yang G, Chen Y, Zhang L, Nan Q. Dong J, et al. Eur J Cancer Prev. 2019 Jan;28(1):10-16. doi: 10.1097/CEJ.0000000000000414. Eur J Cancer Prev. 2019. PMID: 29481338
Saini SD, Kim HM, Schoenfeld P. Saini SD, et al. Gastrointest Endosc. 2006 Oct;64(4):614-26. doi: 10.1016/j.gie.2006.06.057. Gastrointest Endosc. 2006. PMID: 16996358 Review.
Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Winawer SJ, et al. Gastroenterology. 2006 May;130(6):1872-85. doi: 10.1053/j.gastro.2006.03.012. Gastroenterology. 2006. PMID: 16697750 Review.
Calderwood AH, Lasser KE, Roy HK. Calderwood AH, et al. World J Gastrointest Oncol. 2016 Dec 15;8(12):826-834. doi: 10.4251/wjgo.v8.i12.826. World J Gastrointest Oncol. 2016. PMID: 28035253 Free PMC article.
Honda M, Naoe H, Gushima R, Miyamoto H, Tateyama M, Sakurai K, Oda Y, Murakami Y, Tanaka Y. Honda M, et al. PLoS One. 2021 Jan 22;16(1):e0245211. doi: 10.1371/journal.pone.0245211. eCollection 2021. PLoS One. 2021. PMID: 33481809 Free PMC article.
Rosas US, Pan JY, Sundaram V, Su A, Fazal M, Dinh P, Ladabaum U. Rosas US, et al. Gastro Hep Adv. 2022 Jul 31;2(1):132-143. doi: 10.1016/j.gastha.2022.07.014. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39130145 Free PMC article.
Preen DB, Lansdorp-Vogelaar I, Ee HC, Platell C, Cenin DR, Troeung L, Bulsara M, O'Leary P. Preen DB, et al. Front Public Health. 2017 Sep 8;5:234. doi: 10.3389/fpubh.2017.00234. eCollection 2017. Front Public Health. 2017. PMID: 28944221 Free PMC article. No abstract available.
Chung SH, Park SJ, Cheon JH, Park MS, Hong SP, Kim TI, Kim WH. Chung SH, et al. J Korean Med Sci. 2013 Sep;28(9):1345-50. doi: 10.3346/jkms.2013.28.9.1345. Epub 2013 Aug 28. J Korean Med Sci. 2013. PMID: 24015041 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3